Cargando…

Defibrotide inhibits donor leucocyte‐endothelial interactions and protects against acute graft‐versus‐host disease

Allogeneic hematopoietic stem cell transplantation (allo‐HCT) is an effective therapy for the treatment of high‐risk haematological malignant disorders and other life‐threatening haematological and genetic diseases. Acute graft‐versus‐host disease (aGvHD) remains the most frequent cause of non‐relap...

Descripción completa

Detalles Bibliográficos
Autores principales:	García‐Bernal, David, Palomo, Marta, Martínez, Carlos M., Millán‐Rivero, José E., García‐Guillén, Ana I., Blanquer, Miguel, Díaz‐Ricart, Maribel, Sackstein, Robert, Carreras, Enric, Moraleda, Jose M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348164/ https://www.ncbi.nlm.nih.gov/pubmed/32519822 http://dx.doi.org/10.1111/jcmm.15434

Ejemplares similares

Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
por: Martinez-Sanchez, Julia, et al.
Publicado: (2019)

Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
por: Palomo, Marta, et al.
Publicado: (2019)

The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae
por: Richardson, Paul G., et al.
Publicado: (2021)

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group
por: Moraleda, Jose M., et al.
Publicado: (2020)

Endothelial Dysfunction in Hematopoietic Cell Transplantation
por: Palomo, Marta, et al.
Publicado: (2019)

Endothelial dysfunction and its critical role in COVID‐19‐associated coagulopathy: Defibrotide as an endothelium‐protective, targeted therapy
por: García‐Bernal, David, et al.
Publicado: (2021)

Response to Maccio et al, “Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”
por: Richardson, Edward, et al.
Publicado: (2020)

Exofucosylation of Adipose Mesenchymal Stromal Cells Alters Their Secretome Profile
por: García-Bernal, David, et al.
Publicado: (2020)

Endothelial damage and dysfunction in acute graft-versus-host disease
por: Cordes, Steffen, et al.
Publicado: (2020)

Differential protein expression in endothelial cells exposed to serum from patients with acute graft‐vs‐host disease, depending on steroid response
por: Martinez‐Sanchez, Julia, et al.
Publicado: (2023)

Enforced mesenchymal stem cell tissue colonization counteracts immunopathology
por: García-Bernal, David, et al.
Publicado: (2022)

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
por: Blasco, Miquel, et al.
Publicado: (2022)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Binucleated human bone marrow-derived mesenchymal cells can be formed during neural-like differentiation with independence of any cell fusion events
por: Bueno, Carlos, et al.
Publicado: (2022)

Human Wharton’s jelly mesenchymal stem cells protect axotomized rat retinal ganglion cells via secretion of anti-inflammatory and neurotrophic factors
por: Millán-Rivero, Jose E., et al.
Publicado: (2018)

Defibrotide for hepatic veno-occlusive disease
Publicado: (2021)

Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty
por: Moreno-Castaño, Ana Belen, et al.
Publicado: (2020)

Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis
por: Orlando, Nicoletta, et al.
Publicado: (2020)

Pharmacokinetic profile of defibrotide in patients with renal impairment
por: Tocchetti, Paola, et al.
Publicado: (2016)

Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016)

Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects
por: Umemura, Kazuo, et al.
Publicado: (2016)

Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development
por: Moreno-Castaño, Ana Belén, et al.
Publicado: (2022)

P1272: DEFIBROTIDE IMPACT ON THE ACUTE GRAFT-VERSUS-HOST DISEASE INCIDENCE IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.
por: Squillaci, Domenica, et al.
Publicado: (2023)

Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies
por: Elhadad, Sonia, et al.
Publicado: (2023)

Defibrotide Therapy for SARS-CoV-2 ARDS
por: Frame, David, et al.
Publicado: (2022)

Defibrotide Has a Role in COVID-19 Therapy
por: Macciò, Antonio, et al.
Publicado: (2022)

Impact of Graft-Resident Leucocytes on Treg Mediated Skin Graft Survival
por: Steiner, Romy, et al.
Publicado: (2021)

Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy
por: Palomo, Marta, et al.
Publicado: (2022)

Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide
por: Shi, Hui, et al.
Publicado: (2021)

Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report
por: Lee, Tae Beom, et al.
Publicado: (2021)

The Predictive Value of Donor Renal Functions, Graft Weight, Recipient Body Mass Index, and Human Leucocyte Antigen Match Regarding Early Graft Functions
por: Açıkgöz, Onur, et al.
Publicado: (2023)

A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
por: Hudspeth, Michelle, et al.
Publicado: (2022)

Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application
por: Insausti, Carmen L, et al.
Publicado: (2014)

Defibrotide Therapy for Sars CoV2 Acute Respiratory Distress Syndrome
por: Yanik, Gregory A, et al.
Publicado: (2021)

Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide
por: Kong, Seom Gim, et al.
Publicado: (2022)

Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndrome
por: Liu, Zhenli, et al.
Publicado: (2022)

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2022)

NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach
por: Caballo, Carolina, et al.
Publicado: (2012)

Leucocyte function
por: Matera, Lina
Publicado: (1983)

LEUCOCYTIC SECRETIONS
por: Carrel, Alexis, et al.
Publicado: (1922)

Cannot write session to /tmp/vufind_sessions/sess_pmk9eb9dti0nssnsdvfj4es3rg